Akebia Therapeutics
AKBA
AKBA
89 hedge funds and large institutions have $191M invested in Akebia Therapeutics in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
10% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 31
5% less funds holding
Funds holding: 94 → 89 (-5)
9% less capital invested
Capital invested by funds: $210M → $191M (-$18.9M)
Holders
89
Holding in Top 10
2
Calls
$933K
Puts
$322K
Top Buyers
| 1 | +$24.7M | |
| 2 | +$11.7M | |
| 3 | +$2.73M | |
| 4 |
Renaissance Technologies
New York
|
+$1.63M |
| 5 |
Millennium Management
New York
|
+$1.1M |
Top Sellers
| 1 | -$7.28M | |
| 2 | -$5.72M | |
| 3 | -$4.49M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$3.45M |
| 5 |
CFIC
City Financial Investment Company
London,
United Kingdom
|
-$1.21M |